Morphological changes in experimental postischemic rat kidney.: A pilot study

被引:2
作者
Aunapuu, M
Pechter, Ü
Kühnel, W
Ots, M
Arend, A
机构
[1] Univ Tartu, Dept Anat, EE-51014 Tartu, Estonia
[2] Tartu Univ Clin, Dept Internal Med, EE-50406 Tartu, Estonia
[3] Univ Lubeck, Inst Anat, D-23538 Lubeck, Germany
关键词
ischemia-reperfusion; renat corpuscle; basement membrane; epithelial cells; Losartan;
D O I
10.1016/j.aanat.2004.07.002
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 [人体解剖与组织胚胎学];
摘要
of our study was to investigate the changes in the early stages (at weeks 2 and 4) of experimental. acute renal. failure after short-time ischemia-reperfusion (I/R) compared with the impact of Losartan. Twenty mate Wistar rats were divided into three groups: sham-operated rats (2 weeks), I/R groups (2 and 4 weeks); I/R and Losartan-treated groups (2 and 4 weeks). I/R was produced in adult rats by clamping the left kidney renal artery and renal. vein for 40 min. The angiotensin II receptor antagonist Losartan was added to the drinking water (40 mg/l), and treatment was started on the first day after the I/R. Body weight, systolic blood pressure (SBP) and 24h urine amount was measured every week. Urine amount and SBP was higher in I/R groups compared to sham-operated rats. Early stage acute renal disease was characterized by focal segmental glomerulosclerosis (FSGS) and interstitial fibrosis (IF) at weeks 2 and 4 after I/R. In the Losartan group, 2 weeks after the surgery, FSGS, IF and mesangial cell proliferation was decreased, but at week 4 these parameters showed a tendency to increase. Marked changes take place in tubular epithelial cells, especially in I/R groups. Angiotensin II receptor blocker AT(1)RA Losartan in the small dose (40 mg/L) had no effect on hypertension and urine excretion in the experimental, I/R model. A pilot study revealed that tubular basement membrane thickness is markedly increased after I/R. (c) 2004 Elsevier GmbH. All, rights reserved.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 18 条
[1]
Chatterjee Prabal K, 2003, Methods Mol Biol, V225, P223
[2]
CRARY GS, 1995, J AM SOC NEPHROL, V6, P1295
[3]
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury [J].
Deng, JP ;
Kohda, Y ;
Chiao, H ;
Wang, YQ ;
Hu, XH ;
Hewitt, SM ;
Miyaji, T ;
McLeroy, P ;
Nibhanupudy, B ;
Li, SJ ;
Star, RA .
KIDNEY INTERNATIONAL, 2001, 60 (06) :2118-2128
[4]
Ischemic acute renal failure: Long-term histology of cell and matrix changes in the rat [J].
Forbes, JM ;
Hewitson, TD ;
Becker, GJ ;
Jones, CL .
KIDNEY INTERNATIONAL, 2000, 57 (06) :2375-2385
[5]
Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury [J].
Gobé, G ;
Willgoss, D ;
Hogg, N ;
Schoch, E ;
Endre, Z .
KIDNEY INTERNATIONAL, 1999, 56 (04) :1299-1304
[7]
Heyman Samuel N, 2002, Curr Opin Crit Care, V8, P526, DOI 10.1097/00075198-200212000-00008
[8]
Ischaemia-reperfusion injury in the rat kidney: The effect of preconditioning [J].
Islam, CF ;
Mathie, RT ;
Dinneen, MD ;
Kiely, EA ;
Peters, AM ;
Grace, PA .
BRITISH JOURNAL OF UROLOGY, 1997, 79 (06) :842-847
[9]
Role of AT1 angiotensin II receptors in renal ischemic injury [J].
Kontogiannis, J ;
Burns, KD .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (01) :F79-F90
[10]
Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis [J].
Padanilam, BJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (04) :F608-F627